Posted in | News

WowJoint Holding to Build New Manufacturing and R&D Facility

Chinese infrastructure solutions provider WowJoint Holdings has announced that it will construct a new manufacturing and R&D facility in Zhenjiang City New District.

Related Stories

A formal ground breaking ceremony towards this end was held recently. The new facility will be operated by Zhenjiang WowJoint Heavy Duty Machinery Co.

The manufacturing facility will cover an area of 200,000 sq.m which will include a production workshop over 14,000 sq.m and 7,000 sq.m for office space, testing grounds and shipping fields. The construction will be carried out in two phases where the first phase will be completed in six months. The manufacturing facility will be used for production and maintenance of railway testing and transportation equipment and lifting equipment. The R&D facility will be located within this manufacturing facility and will be operated in collaboration with the Yangtze River Delta R&D Transporation Institute of Beijing Jiaotong University. The R&D centre will work in collaboration with the manufacturing facility in order to supply equipment and other services to the customers of WowJoint. More focus will be given to rail transportation and logistics projects in South China and global markets. The CEO of WowJoint Yabin Liu believes that the proximity of the facility to Shanghai will help the company to utilise its resources to the maximum capability, which in turn will help in their future expansion plans.

Source: http://www.wowjoint.com

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). WowJoint Holding to Build New Manufacturing and R&D Facility. AZoBuild. Retrieved on November 22, 2024 from https://www.azobuild.com/news.aspx?newsID=15311.

  • MLA

    Scanlon, Joel. "WowJoint Holding to Build New Manufacturing and R&D Facility". AZoBuild. 22 November 2024. <https://www.azobuild.com/news.aspx?newsID=15311>.

  • Chicago

    Scanlon, Joel. "WowJoint Holding to Build New Manufacturing and R&D Facility". AZoBuild. https://www.azobuild.com/news.aspx?newsID=15311. (accessed November 22, 2024).

  • Harvard

    Scanlon, Joel. 2019. WowJoint Holding to Build New Manufacturing and R&D Facility. AZoBuild, viewed 22 November 2024, https://www.azobuild.com/news.aspx?newsID=15311.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit
Reducing Embodied Carbon Through Design

Reducing Embodied Carbon Through Design

With an increase in the pressure to decarbonize the built environment and build more carbon-neutral buildings, the reduction of embodied carbon has become of great importance.

Calcium Carbonate Concrete: Building on Recycling

Calcium Carbonate Concrete: Building on Recycling

AZoBuild talks to Professors Noguchi and Maruyama about their research and development of Calcium Carbonate Concrete (CCC), a new material that has the potential to cause a sustainable revolution in the construction industry.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback